{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:22:36Z","timestamp":1758280956455,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["Italian Ministry of Health RF2013-02358960 grant, Italian Ministry of Health COVID-2020-12371817 grant, grant \u201c5 per mille, 2021\u201d"],"award-info":[{"award-number":["Italian Ministry of Health RF2013-02358960 grant, Italian Ministry of Health COVID-2020-12371817 grant, grant \u201c5 per mille, 2021\u201d"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>A 48-year-old patient affected with congenital generalized lipodystrophy type 4 failed to respond to two doses of the BNT162b2 vaccine, consisting of lipid nanoparticle encapsulated mRNA. As the disease is caused by biallelic variants of <jats:italic>CAVIN1<\/jats:italic>, a molecule indispensable for lipid endocytosis and regulation, we complemented the vaccination cycle with a single dose of the Ad26.COV2 vaccine. Adenovirus-based vaccine entry is mediated by the interaction with adenovirus receptors and transport occurs in clathrin-coated pits. Ten days after Ad26.COV2 administration, S- and RBD-specific antibodies and high-affinity memory B cells increased significantly to values close to those observed in Health Care Worker controls.<\/jats:p>","DOI":"10.3389\/fimmu.2022.869042","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T05:23:06Z","timestamp":1649222586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Precision COVID-19 Immunization Strategy to Overcome Individual Fragility: A Case of Generalized Lipodystrophy Type 4"],"prefix":"10.3389","volume":"13","author":[{"given":"Salvatore","family":"Zaffina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Piano Mortari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reparata Rosa","family":"Di Prinzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Agolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Raponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Dallapiccola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Carsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital Generalized Lipodystrophies\u2014New Insights Into Metabolic Dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2009.01023.x","article-title":"Biogenesis of Caveolae: Stepwise Assembly of Large Caveolin and Cavin Complexes","volume":"11","author":"Hayer","year":"2010","journal-title":"Traffic"},{"key":"B3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1582-4934.2008.00295.x","article-title":"Caveolae Structure and Function","volume":"12","author":"Thomas","year":"2008","journal-title":"J Cell Mol Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature03866","article-title":"Kinase-Regulated Quantal Assemblies and Kiss-and-Run Recycling of Caveolae","volume":"436","author":"Pelkmans","year":"2005","journal-title":"Nat"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38660","article-title":"Human PTRF Mutations Cause Secondary Deficiency of Caveolins Resulting in Muscular Dystrophy With Generalized Lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine Against SARS-CoV-2 \u2014 Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"New Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.Cov2.S Vaccine Against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-Lipid Nanoparticle COVID-19 Vaccines: Structure and Stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int J Pharm"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41541-021-00369-6","article-title":"Distinguishing Features of Current COVID-19 Vaccines: Knowns and Unknowns of Antigen Presentation and Modes of Action","volume":"6","author":"Heinz","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"22777","DOI":"10.1038\/s41598-021-02321-z","article-title":"Comparing the Clinical Efficacy of COVID-19 Vaccines: A Systematic Review and Network Meta-Analysis","volume":"11","author":"Rotshild","year":"2021","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3390\/cells10102541","article-title":"Highly Specific Memory B Cells Generation After the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA","volume":"10","author":"Piano Mortari","year":"2021","journal-title":"Cells"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/cells10112915","article-title":"B Cell Response Induced by SARS-CoV-2 Infection is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies","volume":"10","author":"Pulvirenti","year":"2021","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01133-0","article-title":"SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does Their Best","volume":"41","author":"Salinas","year":"2021","journal-title":"J Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid Nanoparticles for mRNA Delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.11.020","article-title":"The Role of Caveolin-1 in the Biofate and Efficacy of Anti-Tumor Drugs and Their Nano-Drug Delivery Systems","volume":"11","author":"Yang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27463","article-title":"COVID-19 Vaccines Mix-and-Match: The Concept, the Efficacy and the Doubts","volume":"94","author":"Rashedi","year":"2022","journal-title":"J Med Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es.2021.26.47.2101021","article-title":"Estimated Number of Deaths Directly Averted in People 60 Years and Older as a Result of COVID-19 Vaccination in the WHO European Region, December 2020 to November 2021","volume":"26","author":"Mesl\u00e9","year":"2021","journal-title":"Euro Surveillance"},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"Bijker EM. A Guide to Vaccinology: From Basic Principles to New Developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A Systematic Review of SARS-CoV-2 Vaccine Candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.031","article-title":"Impaired Memory B-Cell Response to the Pfizer-BioNTech COVID-19 Vaccine in Patients With Common Variable Immunodeficiency","volume":"149","author":"Fernandez Salinas","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/annrheumdis-2021-220626","article-title":"Humoral and T-Cell Responses to SARS-CoV-2 Vaccination in Patients Receiving Immunosuppression","volume":"80","author":"Prendecki","year":"2021","journal-title":"Ann Rheumatic Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14495","article-title":"SARS-COV-2 Vaccination With BNT162B2 in Renal Transplant Patients: Risk Factors for Impaired Response and Immunological Implications","volume":"36","author":"Russo","year":"2022","journal-title":"Clin Transplantation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41408-021-00534-z","article-title":"Weak Immunogenicity of SARS-CoV-2 Vaccine in Patients With Hematologic Malignancies","volume":"11","author":"Malard","year":"2021","journal-title":"Blood Cancer J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.2000.0468","article-title":"Cell Receptors Involved in Adenovirus Entry","volume":"274","author":"Nemerow","year":"2000","journal-title":"Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral Vector Vaccine Platforms in the SARS-CoV-2 Pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B26","unstructured":"FDA Safety CommunicationAntibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination2021"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn Errors of Type I IFN Immunity in Patients With Life-Threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies Against Type I IFNs in Patients With Life-Threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139557","article-title":"Clinical Relevance of- Limit of Detection (LOD) - Limit of Quantification (LOQ) - Based Flow Cytometry Approach for Measurable Residual Disease (MRD) Assessment in Acute Myeloid Leukemia (AML)","volume":"136","author":"Buccisano","year":"2020","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21591","article-title":"Early Recovery of Circulating Immature B Cells in B-Lymphoblastic Leukemia Patients After CD19 Targeted CAR T Cell Therapy: A Pitfall for Minimal Residual Disease Detection","volume":"94","author":"Xiao","year":"2018","journal-title":"Cytometry Part B - Clin Cytometry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/cyto.b.21609","article-title":"ICCS\/ESCCA Consensus Guidelines to Detect GPI-Deficient Cells in Paroxysmal Nocturnal Hemoglobinuria (PNH) and Related Disorders Part 3 \u2013 Data Analysis, Reporting and Case Studies","volume":"94","author":"Illingworth","year":"2018","journal-title":"Cytometry Part B: Clin Cytometry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.869042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T05:23:22Z","timestamp":1649222602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.869042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2022.869042"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.869042","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"article-number":"869042"}}